Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

BACKGROUND: Lenvatinib has proven efficacy in progressive, radioiodine- (RAI-) refractory thyroid cancer (TC). Dose reductions are commonly performed due to decreased tolerability and adverse effects. This retrospective multicenter study analyzed overall survival (OS) and progression-free survival (...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Int J Endocrinol
Main Authors: Rendl, G., Sipos, B., Becherer, A., Sorko, S., Trummer, C., Raderer, M., Hitzl, W., Ardelt, M., Gallowitsch, H. J., Pirich, C.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Hindawi 2020
Ábhair:
Research Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719524/
https://ncbi.nlm.nih.gov/pubmed/33312196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8834148
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla